Description:

Program Objectives

After attending this educational activity, participants should be able to:

1) Recognize the latest developments in the diagnosis and treatment of pulmonary disorders.
2) Describe the risks and benefits of therapeutic options including clinical trials for patients with advanced lung diseases.
3) Discuss multidisciplinary technological advances in the treatment of patients with advanced lung diseases.
4) Explain the role of lung transplantation in the treatment of patients with advanced lung diseases.

Audience
The content of the program is appropriate for pulmonologists and other healthcare providers caring for patients with pulmonary disease.

Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this educational activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.